Home Value Investing Aswath Damodaran – Divergence: The Changing Drug Business

Aswath Damodaran – Divergence: The Changing Drug Business

Advertisement Disclosure: When you purchase through our sponsored links, we may earn a commission from our partners. By using this website you agree to our T&Cs.


Aswath Damodaran Divergence: The Changing Drug Business

Published on Nov 13, 2015

In this session, I look at how the prescription drug business is changing, particularly in the US, and the implications for R&D and investing at these companies.
Slides: http://www.stern.nyu.edu/~adamodar/pd…
Blog post: http://aswathdamodaran.blogspot.com/2…

Our Editorial Standards

At ValueWalk, we’re committed to providing accurate, research-backed information. Our editors go above and beyond to ensure our content is trustworthy and transparent.

Editor
Investing

Which Stocks Should You Buy, and Sell, in 2026?

Dave Kovaleski5 months

Also, the 3 sectors that Wall Street analysts are most bullish about. The usual suspects dominated in 2025 as both the Communication Services and Information Technology sectors helped boost the...